New technologies have always driven advances in clinical research, and that’s still true today. The Covid pandemic rapidly accelerated the adoption of decentralized trials, powered by emerging health tech, but in less dramatic times, life sciences must find ways to ensure continued innovation. As an industry veteran and co-chair of the Digital Trials & Research Alliance (DTRA), Craig Lipset has a powerful perspective on the potential of emerging technologies, and how to successfully combat inertia and encourage adoption in clinical studies. He joins Medidata CEO Anthony Costello to explore the origins of decentralized trials, the potential of Virtual Twins, and how the Buffalo Initiative is promoting research into understudied rare diseases. 00:00 Introduction 05:58 Craig’s Early Career 11:10 The Birth of the Remote Trial 17:41 DTRA’s Origin and Evolving Mission 22:13 Pushing Beyond the Hype Cycle 30:18 Driving Adoption of New Clinical Trial Technologies 36:41 Incentivizing Innovation 41:40 The Buffalo Initiative: Parent-Powered Research 49:45 The Potential of Virtual Twins 1:00:02 Craig’s Call-to-Action: Embracing Technology and Change Visit our website: https://mdso.io/63cddc Read our blog: https://mdso.io/ze1 Follow Medidata LinkedIn: https://mdso.io/s7r Instagram: https://mdso.io/rng X: https://mdso.io/8du Follow Anthony LinkedIn: https://mdso.io/mfp Follow Craig LinkedIn: https://mdso.io/wq7

 59      0